A phase II trial (N0177) of erlotinib and temozolomide (TMZ) combined with radiation therapy (RT) in glioblastoma multiforme (GBM)

被引:4
作者
Brown, P. D.
Krishnan, S.
Sarkaria, J.
Wu, W.
Mischel, P.
Yong, W. H.
Arusell, R.
Jenkins, R. B.
Buckner, J. C.
Giannini, C.
机构
[1] Mayo Clin, Rochester, MN USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Univ Calif Los Angeles, Los Angeles, CA USA
[4] Roger Maris Canc Ctr, Fargo, ND USA
关键词
D O I
10.1200/jco.2008.26.15_suppl.2016
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2016
引用
收藏
页数:1
相关论文
empty
未找到相关数据